Re-establishment of the Epigenetic State and Rescue of Kinome Deregulation in Ts65Dn Mice Upon Treatment with Green Tea Extract and Environmental Enrichment

Overview

Journal Sci Rep

Specialty Science

Date 2020 Sep 30

PMID 32994493

Citations 11

Authors

I De Toma

M Ortega

S Catuara-Solarz

C Sierra

E Sabido

M Dierssen

Affiliations

Soon will be listed here.

Abstract

Down syndrome (DS) is the main genetic cause of intellectual disability due to triplication of human chromosome 21 (HSA21). Although there is no treatment for intellectual disability, environmental enrichment (EE) and the administration of green tea extracts containing epigallocatechin-3-gallate (EGCG) improve cognition in mouse models and individuals with DS. Using proteome, and phosphoproteome analysis in the hippocampi of a DS mouse model (Ts65Dn), we investigated the possible mechanisms underlying the effects of green tea extracts, EE and their combination. Our results revealed disturbances in cognitive-related (synaptic proteins, neuronal projection, neuron development, microtubule), GTPase/kinase activity and chromatin proteins. Green tea extracts, EE, and their combination restored more than 70% of the phosphoprotein deregulation in Ts65Dn, and induced possible compensatory effects. Our downstream analyses indicate that re-establishment of a proper epigenetic state and rescue of the kinome deregulation may contribute to the cognitive rescue induced by green tea extracts.

Citing Articles

A bibliometric analysis of studies on environmental enrichment spanning 1967-2024: patterns and trends over the years.

Singhal G, Baune B Front Behav Neurosci. 2024; 18:1501377.

PMID: 39697184 PMC: 11652173. DOI: 10.3389/fnbeh.2024.1501377.

The lncRNA Snhg11, a new candidate contributing to neurogenesis, plasticity, and memory deficits in Down syndrome.

Sierra C, Sabariego-Navarro M, Fernandez-Blanco A, Cruciani S, Zamora-Moratalla A, Novoa E Mol Psychiatry. 2024; 29(7):2117-2134.

PMID: 38409595 DOI: 10.1038/s41380-024-02440-9.

Neocortical neuronal production and maturation defects in the TcMAC21 mouse model of Down syndrome.

Kurabayashi N, Fujii K, Otobe Y, Hiroki S, Hiratsuka M, Yoshitane H iScience. 2023; 26(12):108379.

PMID: 38025769 PMC: 10679816. DOI: 10.1016/j.isci.2023.108379.

The lncRNA Snhg11, a new candidate contributing to neurogenesis, plasticity and memory deficits in Down syndrome.

Sierra C, Sabariego-Navarro M, Fernandez-Blanco A, Cruciani S, Zamora-Moratalla A, Novoa E Res Sq. 2023; .

PMID: 37841843 PMC: 10571621. DOI: 10.21203/rs.3.rs-3184329/v1.

Pharmacological Inhibition of p-21 Activated Kinase (PAK) Restores Impaired Neurite Outgrowth and Remodeling in a Cellular Model of Down Syndrome.

Barraza-Nunez N, Perez-Nunez R, Gaete-Ramirez B, Barrios-Garrido A, Arriagada C, Poksay K Neurotox Res. 2023; 41(3):256-269.

PMID: 36867391 DOI: 10.1007/s12640-023-00638-3.

References

de la Torre R, de Sola S, Hernandez G, Farre M, Pujol J, Rodriguez J . Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2016; 15(8):801-810. DOI: 10.1016/S1474-4422(16)30034-5. View

de la Torre R, de Sola S, Pons M, Duchon A, Martinez de Lagran M, Farre M . Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol Nutr Food Res. 2013; 58(2):278-88. DOI: 10.1002/mnfr.201300325. View

Takahashi H, Suzuki Y, Mohamed J, Gotoh T, Pereira S, Alway S . Epigallocatechin-3-gallate increases autophagy signaling in resting and unloaded plantaris muscles but selectively suppresses autophagy protein abundance in reloaded muscles of aged rats. Exp Gerontol. 2017; 92:56-66. PMC: 5501279. DOI: 10.1016/j.exger.2017.02.075. View

Pervin M, Unno K, Ohishi T, Tanabe H, Miyoshi N, Nakamura Y . Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases. Molecules. 2018; 23(6). PMC: 6099654. DOI: 10.3390/molecules23061297. View

Pons-Espinal M, Martinez de Lagran M, Dierssen M . Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A. Neurobiol Dis. 2013; 60:18-31. DOI: 10.1016/j.nbd.2013.08.008. View

Duchon A, Herault Y . DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome. Front Behav Neurosci. 2016; 10:104. PMC: 4891327. DOI: 10.3389/fnbeh.2016.00104. View

De Toma I, Ortega M, Aloy P, Sabido E, Dierssen M . DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment. Front Mol Neurosci. 2019; 12:272. PMC: 6873902. DOI: 10.3389/fnmol.2019.00272. View

Martinez-Cue C, Baamonde C, Lumbreras M, Paz J, Davisson M, Schmidt C . Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome. Behav Brain Res. 2002; 134(1-2):185-200. DOI: 10.1016/s0166-4328(02)00026-8. View

Begenisic T, Spolidoro M, Braschi C, Baroncelli L, Milanese M, Pietra G . Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome. Front Cell Neurosci. 2011; 5:29. PMC: 3245647. DOI: 10.3389/fncel.2011.00029. View

10.

Dierssen M, Benavides-Piccione R, Martinez-Cue C, Estivill X, Florez J, Elston G . Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichment. Cereb Cortex. 2003; 13(7):758-64. DOI: 10.1093/cercor/13.7.758. View

11.

Chakrabarti L, Scafidi J, Gallo V, Haydar T . Environmental enrichment rescues postnatal neurogenesis defect in the male and female Ts65Dn mouse model of Down syndrome. Dev Neurosci. 2011; 33(5):428-41. PMC: 3254041. DOI: 10.1159/000329423. View

12.

Catuara-Solarz S, Espinosa-Carrasco J, Erb I, Langohr K, Notredame C, Gonzalez J . Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome. Front Behav Neurosci. 2015; 9:330. PMC: 4675859. DOI: 10.3389/fnbeh.2015.00330. View

13.

Catuara-Solarz S, Espinosa-Carrasco J, Erb I, Langohr K, Gonzalez J, Notredame C . Combined Treatment With Environmental Enrichment and (-)-Epigallocatechin-3-Gallate Ameliorates Learning Deficits and Hippocampal Alterations in a Mouse Model of Down Syndrome. eNeuro. 2016; 3(5). PMC: 5099603. DOI: 10.1523/ENEURO.0103-16.2016. View

14.

Reeves R, Irving N, Moran T, WOHN A, Kitt C, Sisodia S . A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet. 1995; 11(2):177-84. DOI: 10.1038/ng1095-177. View

15.

Fernandez F, Trinidad J, Blank M, Feng D, Burlingame A, Garner C . Normal protein composition of synapses in Ts65Dn mice: a mouse model of Down syndrome. J Neurochem. 2009; 110(1):157-69. PMC: 2735138. DOI: 10.1111/j.1471-4159.2009.06110.x. View

16.

Peng S, Zhang Y, Zhang J, Wang H, Ren B . ERK in learning and memory: a review of recent research. Int J Mol Sci. 2010; 11(1):222-232. PMC: 2821000. DOI: 10.3390/ijms11010222. View

17.

Tramutola A, Di Domenico F, Barone E, Arena A, Giorgi A, Di Francesco L . Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology. Antioxid Redox Signal. 2016; 26(7):280-298. PMC: 5327052. DOI: 10.1089/ars.2016.6686. View

18.

Lepri F, De Luca A, Stella L, Rossi C, Baldassarre G, Pantaleoni F . SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations. Hum Mutat. 2011; 32(7):760-72. PMC: 3118925. DOI: 10.1002/humu.21492. View

19.

Bartsch O, Schmidt S, Richter M, Morlot S, Seemanova E, Wiebe G . DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet. 2005; 117(5):485-93. DOI: 10.1007/s00439-005-1331-y. View

20.

Granno S, Nixon-Abell J, Berwick D, Tosh J, Heaton G, Almudimeegh S . Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus. Sci Rep. 2019; 9(1):7322. PMC: 6513850. DOI: 10.1038/s41598-019-43820-4. View